BioMedNewsBreaks – IBN, BioMedWire to Deliver Increased Visibility, Reach for DGE’s 2023 Events

IBN (“InvestorBrandNetwork”), a multifaceted communications organization engaged in connecting companies to the investment community through 50+ brands, has announced that it will collaborate with Dynamic Global Events (“DGE”) as an official media partner for upcoming events in 2023. In addition, BioMedWire (“BMW”), a specialized communications platform for the life sciences sector and one of IBN’s 50+ brands, will serve as an official media partner for DGE’s events throughout the coming year. A world leader in life sciences-related conference production, DGE has developed a portfolio of high-quality B2B events that facilitate partnership-building, education and networking throughout the pharmaceutical, health care and allied industries. As part of the collaboration, IBN and BMW will offer dedicated virtual coverage, including syndicated articles with full dissemination to 5000+ strategic syndication partners such as Apple News for the upcoming events. “We are very pleased to be collaborating with IBN and BioMedWire again,” said DGE’s Marketing Manager Elizabeth Stanislaw, MBA. “As market leaders, IBN’s breadth of social media management tools, active syndication network and roster of highly reputed brands deliver excellent visibility. Their targeted approach and finely tuned communications strategies maximize our reach among relevant audiences.”

To view the full press release, visit https://ibn.fm/MF7ra

About IBN

IBN consists of financial brands introduced to the investment public over the course of 17+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through our Dynamic Brand Portfolio (“DBP”), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.

For more information on IBN, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork